Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (AZNCF)
OTHER OTC:AZNCF
AZNCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$120.64 - $175.00
Previous CloseN/A
Volume3.14K
Average Volume (3M)1.93K
Market Cap
£236.69B
Enterprise Value$183.25B
Total Cash (Recent Filing)$5.49B
Total Debt (Recent Filing)$30.11B
Price to Earnings (P/E)34.4
Beta0.35
Next Earnings
Apr 29, 2025EPS Estimate
2.22Last Dividend Ex-Date
Feb 20, 2025Dividend Yield2.03%
Share Statistics
EPS (TTM)4.54
Shares Outstanding1,550,607,200
10 Day Avg. Volume1,335
30 Day Avg. Volume1,933
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)N/A
Price to Sales (P/S)4.31
Price to Cash Flow (P/CF)18.50
P/FCF Ratio25.00
Enterprise Value/Market Cap0.77
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda10.64
Forecast
1Y Price Target
$178.49Price Target Upside18.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessAZN announced positive top-line data from the Phase III SERENA-6 trial investigating Camizestrant in combination with CDK4/6 inhibitors in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumour mutation.
Valuation And Sales ForecastValuation looks attractive with mid-term guide implying high-single digit sales CAGR and supports rerating to 18x 26E P/E.
Bears Say
Safety ConcernsSafety remains a debate with stomatitis/mucositis and now with one ILD-related death.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.02% Insiders
14.32% Mutual Funds
0.01% Other Institutional Investors
77.07% Public Companies and Individual Investors
AZNCF FAQ
What was AstraZeneca PLC’s price range in the past 12 months?
AstraZeneca PLC lowest stock price was $120.64 and its highest was $175.00 in the past 12 months.
What is AstraZeneca PLC’s market cap?
AstraZeneca PLC’s market cap is £236.69B.
When is AstraZeneca PLC’s upcoming earnings report date?
AstraZeneca PLC’s upcoming earnings report date is Apr 29, 2025 which is in 48 days.
How were AstraZeneca PLC’s earnings last quarter?
AstraZeneca PLC released its earnings results on Feb 06, 2025. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.07 by $0.02.
Is AstraZeneca PLC overvalued?
According to Wall Street analysts AstraZeneca PLC’s price is currently Undervalued.
Does AstraZeneca PLC pay dividends?
AstraZeneca PLC pays a Annually dividend of $2.165 which represents an annual dividend yield of 2.03%. See more information on AstraZeneca PLC dividends here
What is AstraZeneca PLC’s EPS estimate?
AstraZeneca PLC’s EPS estimate is 2.22.
How many shares outstanding does AstraZeneca PLC have?
AstraZeneca PLC has 1,550,607,200 shares outstanding.
What happened to AstraZeneca PLC’s price movement after its last earnings report?
AstraZeneca PLC reported an EPS of $2.09 in its last earnings report, beating expectations of $2.07. Following the earnings report the stock price went up 12.497%.
Which hedge fund is a major shareholder of AstraZeneca PLC?
Currently, no hedge funds are holding shares in AZNCF
---
AstraZeneca Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$178.49 (18.44% Upside)
$178.49 (18.44% Upside)
Insider Transactions
Bought Shares
Worth £151.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.1%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.56%
12-Months-Change
Fundamentals
Return on Equity
17.43%
Trailing 12-Months
Asset Growth
4.72%
Trailing 12-Months
Company Description
AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
---
AZNCF Stock 12 Month Forecast
Average Price Target
$178.49
▲(18.44% Upside)
Technical Analysis
Best Analysts Covering AZNCF
1 Year
1 Year Success Rate
27/30 ratings generated profit
1 Year Average Return
+15.35%
reiterated a buy rating 3 days ago
Copying Matthew Weston's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +15.35% per trade.
---